• Explore /
  • Poster
  • / CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC).

CD68+ tumor-associated myeloid cells as the target of adenosine-induced gene products and predictor of response to adenosine blockade with ciforadenant (cifo) in renal cell cancer (RCC).

Abstract Poster

Authors

Martin Voss

Martin H Voss

Memorial Sloan Kettering Cancer Center, New York, NY

Martin H Voss , Andrew N. Hotson , Stephen Willingham , Brett Gordon Maxwell Hughes , Jaime R. Merchan , Lawrence Fong , Michael Chu , Saby George , Brian Munneke , Mehrdad Mobasher , Richard A. Miller

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Biologic Correlates

Clinical Trial Registration Number

NCT02655822

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5025)

DOI

10.1200/JCO.2020.38.15_suppl.5025

Abstract #

5025

Poster Bd #

94

Abstract Disclosures

Similar Posters

First Author: Jennifer Hsing Choe

First Author: Colin Wood

First Author: Chase Allain Shipp

First Author: Keerthi Gullapalli